This solution involves advanced CRISPR-Cas12a gene editing to increase provitamin D3 levels in tomatoes by targeting the SlDWF5A and SlDET2A genes. It aims to produce tomatoes with higher nutritional value for the processed food industry.
The proposed solution focuses on using metabolic engineering to significantly boost the provitamin D3 content in tomatoes. By targeting and knocking out specific genes, namely SlDWF5A and SlDET2A, the technology seeks to enhance the nutritional value of tomatoes, making them a more viable source of vitamin D3, particularly for the processed tomato industry. The solution is particularly beneficial for individuals with genetic predispositions requiring higher vitamin D3 intake.
Key features:
This technology is currently at a TRL of 3, indicating it is in the active research and proof-of-concept stage. The ongoing work involves detailed genetic editing and validation in multiple tomato varieties, with a focus on stabilizing traits that ensure high provitamin D3 levels for future commercial use.
Bayer’s vision of #HealthForAll, #HungerForNone drives our need to strengthen innovation capabilities in all areas of agriculture. We know we can’t accomplish this alone, so we're always interested to hear about novel, early-stage scientific innovations that can contribute to feeding the world without starving the planet. You have our commitment to take a look, match with our R&D priorities and provide you timely feedback.